Phase 2a Study of VTX3232 in Parkinson's Disease

Inclusion Criteria

• •Participants must be ≥ 40 years up to 80 years of age, inclusive, at the time of signing the informed consent, with BMI \> 18.5 and \< 32.0 kg/m2 and body weight ≥ 50.0 kg for males and ≥ 45.0 kg for females.
• •Diagnosis of idiopathic Parkinson's Disease between 0 and 60 months prior to screening.
• •Score of 2 or less on Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part IV at screening.
• •Have not received prior treatment with deep brain stimulation (DBS).
• •If receiving treatment with symptomatic PD therapies, treatment must be stable. Note: The Medical Monitor should be contacted with any questions regarding concomitant therapies.